These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8087553)

  • 1. Biological implications of a 3 A structure of dimeric antithrombin.
    Carrell RW; Stein PE; Fermi G; Wardell MR
    Structure; 1994 Apr; 2(4):257-70. PubMed ID: 8087553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
    Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
    J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin.
    Skinner R; Chang WS; Jin L; Pei X; Huntington JA; Abrahams JP; Carrell RW; Lomas DA
    J Mol Biol; 1998; 283(1):9-14. PubMed ID: 9761669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II antithrombin deficiency caused by a large in-frame insertion: structural, functional and pathological relevance.
    Martínez-Martínez I; Johnson DJ; Yamasaki M; Navarro-Fernández J; Ordóñez A; Vicente V; Huntington JA; Corral J
    J Thromb Haemost; 2012 Sep; 10(9):1859-66. PubMed ID: 22758787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin and its deficiency states.
    Lane DA; Olds RR; Thein SL
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):315-41. PubMed ID: 1643210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
    Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile reactive centre of serpins and the control of thrombosis.
    Carrell RW; Evans DL; Stein PE
    Nature; 1991 Oct; 353(6344):576-8. PubMed ID: 1922367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
    Futamura A; Beechem JM; Gettins PG
    Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity.
    McCoy AJ; Pei XY; Skinner R; Abrahams JP; Carrell RW
    J Mol Biol; 2003 Feb; 326(3):823-33. PubMed ID: 12581643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions.
    Huntington JA; McCoy A; Belzar KJ; Pei XY; Gettins PG; Carrell RW
    J Biol Chem; 2000 May; 275(20):15377-83. PubMed ID: 10809774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A beta-sheet of the inhibitor during trapping of target proteinases.
    Björk I; Nordling K; Olson ST
    Biochemistry; 1993 Jul; 32(26):6501-5. PubMed ID: 7687144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
    Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
    J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.
    Schreuder HA; de Boer B; Dijkema R; Mulders J; Theunissen HJ; Grootenhuis PD; Hol WG
    Nat Struct Biol; 1994 Jan; 1(1):48-54. PubMed ID: 7656006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.
    Skinner R; Abrahams JP; Whisstock JC; Lesk AM; Carrell RW; Wardell MR
    J Mol Biol; 1997 Feb; 266(3):601-9. PubMed ID: 9067613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin and its inherited deficiencies.
    Perry DJ
    Blood Rev; 1994 Mar; 8(1):37-55. PubMed ID: 8205009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial activation of antithrombin without heparin through deletion of a unique sequence on the reactive site loop of the serpin.
    Rezaie AR
    J Biol Chem; 2002 Jan; 277(2):1235-9. PubMed ID: 11707451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.